introduces the basic problem of population overlap even when highly specific markers are used [9] . The use of fluorescence in situ hybridization (FISH) [10, 11] , aneuploidy [12, 13] or single-gene disorders such as cystic fibrosis [14] and haemoglobinopathies, including thalassemia [15] [16] [17] . Fetal erythroblasts have turned out to be difficult to handle, as they show evidence of apoptosis [18, 19] and nucleic shrinking when exposed to the pO2 of maternal blood, leading to low FISH efficiency [19] . Furthermore, only a minor fraction express the chain of haemoglobin (Hb), a specific marker for discrimination of embryonic and early fetal erythroblasts from maternal ones [16, 20] . In the 15 th [26] and reverse XY-FISH [27] but [28] and, in combination, for molecular genetic diagnosis [29] .
(mean) week of pregnancy, approximately half of the erythroblasts in the maternal circulation were proved to be of fetal origin [21]. Thus, pooling of fetal cells to increase the efficiency of PCR analysis can result in contamination with maternal cells. The trophoblast cell, which originates from the placenta rather than from the foetus, still carries the fetal genome. This cell type can be expanded after enrichment by subsequent short-term culture [22]. Although biochemical markers exist for specific labelling of trophoblast cells and Hb-positive erythroblasts, allowing them to be allocated to a candidate fetal cell status under the conditions of rare cell analysis, the identification of the fetal character of other interesting target cells such as fetal stem cells or progenitor cells [23-25] relies almost exclusively on a molecular genetic basis, using Y-FISH or multiplex PCR of polymorphic small tandem repeat (STR) loci. FISH has been optimized to fit rare cell conditions using two different Y probes

the identification of fetal cells based on Y-FISH does not allow for a diagnosis in the case of female foetuses. Multiplex PCR using microsatellite loci is most promising, as it allows for sex-independent identification of cells
Although PCR on single unfixed cells has been established, the analysis of fixed and stained rare cells remains a challenge [30] . [10, 28, 30, 31] . DNA fingerprinting should be set to improve the identification of single cells; however, the costs of using commercially available kits should not be overlooked. Recently, low-volume PCR carried out on a DNA dilution series showed that DNA fingerprinting yields a full profile from as little as 32 pg of DNA [32] . This technique allows cell lysis and subsequent DNA amplification from end volumes of 1.5 l on a chemically modified chip that is designed for optimal control of microdissected cells.
In addition to procedure-related DNA degradation due to fixation and staining, single-cell PCR is prone to PCR failure, allele drop-out (ADO) and the appearance of artificial alleles (allele drop-in [ADI])
In 
Antibodies
To enrich and label trophoblast cells, we used the mouse monoclonal antibodies GZ 112 and GZ 158, both of IgG1 isotype. GZ 112 has been described previously [33] . GZ 158 was generated from a fusion of P3-NS1-Ag4-1 myeloma cells with spleen cells from a BALB/c mouse immunized with homogenized Jeg-3 human choriocarcinoma cells according to the method described by Goding [34] . The [37] . Prior to the analysis, the software was trained to detect fetal erythroblasts (preparation described in Ref. [38] 
DNA profiles and PCR efficiency PCR profiles were assessed by combining all DNA profiles from one and the same sample. Samples yielding at least one amplification product ('successful PCR') were included in the analysis. The lack of PCR fragments at single heterozygous or homozygous loci (no call) was defined as 'amplification failure'. This was calculated from the number of failed loci divided by the total number of loci. ADO and heterozygous patterns were calculated from the results given by heterozygous loci only. ADI was defined as extra PCR fragments that either did not match both respective PCR profiles or matched the other (PBMNC or JAR, maternal or fetal) profile in cases in which contamination was unlikely (single-cell PCR). ADI was also calculated from heterozygous and homozygous loci. PCR efficiency is expressed as successfully amplified alleles at heterozygous loci based on the theoretically maximal number of PCR fragments at heterozygous loci.
Results
Specificity and binding characteristics of the anti-trophoblast antibodies
Automatic cell detection
Performance of single rare cell analysis
In order to assess the feasibility of the method, pooled and single cells in both experimental settings were microdissected and amplified and then the PCR products were analysed (example in Fig. 5 -- 
Contamination experiments of JAR cells in PBMNC
Discussion
The novelty of the method described is that it links automated cell detection based on automatic screening of cells labelled by immunofluorescence with laser catapulting of candidate target cells to reaction sites of slides designed for low-volume on-chip PCR. DNA fingerprint analysis performed in a volume of less than 2 l is shown to be compatible with the preceding processing of cells for pre-identification (establishment of candidate status), making use of DNA profiles as powerful sex-independent markers in single-cell analysis. NIPD based on cells circulating in the blood of pregnant women requires that cells carrying the fetal genome be reliably identified. Some of our pools of cells collected on the basis of immunofluorescence staining show signs of contamination with maternal cells even for target cells that were not rare, such as in the case of the analysis of fetal and maternal cells from the placenta. Because of the even more limited reliability of biochemical markers or FISH in a setting of rare cell analysis, we suggest single-cell DNA profiling as a standard for the identification of these rare cells. Our approach consists basically of two steps: (i) definition of a group of candidate cells by a biochemical marker that need not be perfectly specific but of relevant sensitivity for the detection of fetal cells, and (ii) confirmation of the genomic identity of target cells based on DNA profile. Our data confirm the feasibility of this method on single immunocytochemically stained and lasercatapulted cells, proving the discriminative power between 'rare' JAR choriocarcinoma cells and contaminated PBMNCs and also between single cells that share a haploid set of chromosomes. The multiplex PCR used for the identification might be combined with an analysis of specific monogenetic genomic disease markers. Work is under way to implement whole-genome amplification of single cells so that part of the expanded genome may be used for the identification on the basis of multiplex PCR and the rest of the DNA of confirmed fetal cells may be pooled and used for molecular genetic analysis of, for example, monogenetic diseases or chromosome aberrations by array comparative genomic hybridization (CGH). A pre-condition for a diagnostic test is cost-effectiveness, with NIPD not being an exception. An important step in this direction is the automation of fetal candidate cell location using a slide screening device; in this way, a virtual enrichment step is added to antecedent physical enrichment steps, which we found satisfactorily efficient. For LMPC, automatic relocation of the cells of interest eliminates the labour-intensive step of cell retrieval. In previous work, multiplex PCR of STR markers and amelogenin was used with low-volume on-chip PCR, demonstrating its
-- ------ [10, 12, 15, 21, 28, 31, 40] . PCR performance after histochemical stainings such as May-Grünwald Giemsa, haematoxylin or Wright staining are reported to result in amplification failure from 10% to 58% in cases in which erythroblasts were analysed [10, 15, 21, 28] . ADO or contamination occurred in 25-62% of the cases; uninformative loci were observed in 12.5-62.5% of the cases in which STR markers were used [15, 28] . Apart from a few samples, the high number of uninformative cases of the latter resulted from a low number of STR markers used for identification purposes [15] . We assume that 16- 
